D.A. Davidson & Co’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-7,480
| Closed | -$301K | – | 1480 |
|
2024
Q4 | $301K | Buy |
7,480
+3,636
| +95% | +$146K | ﹤0.01% | 1200 |
|
2024
Q3 | $243K | Buy |
+3,844
| New | +$243K | ﹤0.01% | 1245 |
|
2021
Q4 | – | Sell |
-12,500
| Closed | -$79K | – | 1310 |
|
2021
Q3 | $79K | Hold |
12,500
| – | – | ﹤0.01% | 1188 |
|
2021
Q2 | $75K | Buy |
12,500
+1,000
| +9% | +$6K | ﹤0.01% | 1170 |
|
2021
Q1 | $73K | Buy |
+11,500
| New | +$73K | ﹤0.01% | 1136 |
|
2019
Q4 | – | Sell |
-16,150
| Closed | -$111K | – | 1063 |
|
2019
Q3 | $111K | Sell |
16,150
-150
| -0.9% | -$1.03K | ﹤0.01% | 960 |
|
2019
Q2 | $135K | Buy |
16,300
+580
| +4% | +$4.8K | ﹤0.01% | 930 |
|
2019
Q1 | $156K | Buy |
15,720
+2,065
| +15% | +$20.5K | ﹤0.01% | 1062 |
|
2018
Q4 | $104K | Buy |
+13,655
| New | +$104K | ﹤0.01% | 1048 |
|